Straits Times Index
3,176.51 -11.15 (-0.35%) Nikkei
37,068.35 -1,011.35 (-2.66%) Hang Seng
16,224.14 -161.73 (-0.99%) FTSE 100
7,895.85 +18.80 (+0.24%) Bitcoin USD
64,142.50 +2,063.86 (+3.32%) CMC Crypto 200
1,371.97 +59.34 (+4.52%)
Augmedix, Inc. (AUGX)
After hours:
| Previous close | 3.0100 |
| Open | 3.0300 |
| Bid | 2.9700 x 200 |
| Ask | 3.0200 x 100 |
| Day's range | 2.8200 - 3.1200 |
| 52-week range | 2.6200 - 6.2500 |
| Volume | |
| Avg. volume | 373,249 |
| Market cap | 145.732M |
| Beta (5Y monthly) | -0.13 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- GlobeNewswire
Augmedix Integrates with Andor Health to Revolutionize Ambient Clinical Documentation for Ambulatory Virtual Care
SAN FRANCISCO and ORLANDO, Fla., April 09, 2024 (GLOBE NEWSWIRE) -- In a significant move to streamline healthcare workflows and allow clinicians to focus on patient care, Augmedix (Nasdaq: AUGX), a leader in ambient AI medical documentation and data solutions, announced today that it has integrated with Andor Health, an AI-first cloud-based communication and collaboration platform for virtual care. The alliance aims to harness the power of ambient documentation to transform the clinician-patien
- GlobeNewswire
Augmedix and SADA Forge Partnership to Scale Ambient Documentation and Structured Data Products to Health Systems Nationwide
The partnership enables Augmedix to accelerate scaling efforts for digital health solutions and integrations that work seamlessly at the point of careSAN FRANCISCO, April 04, 2024 (GLOBE NEWSWIRE) -- Augmedix (Nasdaq: AUGX), a leader in ambient AI medical documentation and data solutions, today announced its go-to-market partnership with SADA, an Insight company, a leading cloud business and technology consultancy. The collaboration is focused on leveraging the companies’ combined technology exp
- GlobeNewswire
Augmedix Delivers 45% Revenue Growth and Expanded Gross Margins for Fourth Quarter of 2023
SAN FRANCISCO, March 18, 2024 (GLOBE NEWSWIRE) -- Augmedix (Nasdaq: AUGX), a leader in ambient AI medical documentation and data solutions, today reported financial results for the three and 12 months ended December 31, 2023. “The fourth quarter was a solid end to a strong year for Augmedix both operationally and financially,” stated Augmedix CEO Manny Krakaris. “We delivered a 45% increase in revenue to $12.7 million, ahead of our most recent guidance, driven by a 44% increase in clinicians in
